share_log

泽璟制药(688266.SH):2023年净亏损2.79亿元

Zejing Pharmaceutical (688266.SH): net loss of 279 million yuan in 2023

Gelonghui Finance ·  Apr 19 05:56

Gelonghui, April 19丨Zejing Pharmaceutical (688266.SH) released its 2023 annual report. During the reporting period, it achieved operating income of 386 million yuan, an increase of 27.83% over the previous year; net profit attributable to shareholders of listed companies - 279 million yuan; basic earnings per share - 1.09 yuan.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment